Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 8;11(1):23623.
doi: 10.1038/s41598-021-03063-8.

PET imaging of brain aromatase in humans and rhesus monkeys by 11C-labeled cetrozole analogs

Affiliations

PET imaging of brain aromatase in humans and rhesus monkeys by 11C-labeled cetrozole analogs

Kayo Takahashi et al. Sci Rep. .

Abstract

Aromatase is an estrogen synthetic enzyme that plays important roles in brain functions. To quantify aromatase expression in the brain by positron emission tomography (PET), we had previously developed [11C]cetrozole, which showed high specificity and affinity. To develop more efficient PET tracer(s) for aromatase imaging, we synthesized three analogs of cetrozole. We synthesized meta-cetrozole, nitro-cetrozole, and iso-cetrozole, and prepared the corresponding 11C-labeled tracers. The inhibitory activities of these three analogs toward aromatase were evaluated using marmoset placenta, and PET imaging of brain aromatase was performed using the 11C-labeled tracers in monkeys. The most promising analog in the monkey study, iso-cetrozole, was evaluated in the human PET study. The highest to lowest inhibitory activity of the analogs toward aromatase in the microsomal fraction from marmoset placenta was in the following order: iso-cetrozole, nitro-cetrozole, cetrozole, and meta-cetrozole. This order showed good agreement with the order of the binding potential (BP) of each 11C-labeled analog to aromatase in the rhesus monkey brain. A human PET study using [11C]iso-analog showed a similar distribution pattern of binding as that of [11C]cetrozole. The time-activity curves showed that elimination of [11C]iso-cetrozole from brain tissue was faster than that of 11C-cetrozole, indicating more rapid metabolism of [11C]iso-cetrozole. [11C]Cetrozole has preferable metabolic stability for brain aromatase imaging in humans, although [11C]iso-cetrozole might also be useful to measure aromatase level in living human brain because of its high binding potential.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The chemical structures of [11C]cetrozole (A) and its analogs, [11C]meta-cetrozole (B), [11C]nitro-cetrozole (C), and [11C]iso-cetrozole (D). The methyl moiety in [11C]meta-cetrozole showed a different position from that in [11C]cetrozole. [11C]Nitro-cetrozole contained a nitro group instead of the cyano group of [11C]cetrozole. [11C]Iso-cetrozole showed a different nitrogen position in the triazole in comparison with [11C]cetrozole.
Figure 2
Figure 2
The distribution volume ratio images of [11C]cetrozole (A), [11C]meta-cetrozole (B), [11C]nitro-cetrozole (C), and [11C]iso-cetrozole (D) in rhesus monkey brain (coronal section). The slices contain the amygdala indicated by arrowhead. The scale ranges of the color bar are 0.4–1.5 for [11C]cetrozole, [11C]meta-cetrozole, and [11C]nitro-cetrozole, and 0.4–2.0 for [11C]iso-cetrozole.
Figure 3
Figure 3
BPND values in the amygdala, hypothalamus, nucleus accumbens, and the white matter of [11C]cetrozole, [11C]meta-cetrozole, [11C]nitro-cetrozole, and [11C]iso-cetrozole (N = 4, mean ± S.E.) in rhesus monkey brain. [11C]Meta-cetrozole showed a lower BPND than [11C]cetrozole in the amygdala, hypothalamus, and nucleus accumbens (**P < 0.01). [11C]Iso-cetrozole showed a higher BPND than [11C]cetrozole in the amygdala, nucleus accumbens (*P < 0.05), and hypothalamus (**P < 0.01).
Figure 4
Figure 4
Time-activity curves of [11C]-cetrozole (A), [11C]meta-cetrozole (B), [11C]nitro-cetrozole (C), and [11C]iso-cetrozole (D) in rhesus monkey brain (N = 4, mean ± S.E.). Aromatase-rich regions (amygdala, hypothalamus, and nucleus accumbens), nonspecific region (white matter), and reference region for Logan reference tissue model analysis (cerebellum) are shown.
Figure 5
Figure 5
The representative SUV images of [11C]cetrozole (A,B) and [11C]iso-cetrozole (C,D) in the brains of similar individuals (A,C transaxial slices; B,D sagittal slices). Arrow heads indicate the thalamus.
Figure 6
Figure 6
Time-activity curves of [11C]cetrozole (A, N = 21) and [11C]iso-cetrozole (B, N = 6) in the human brain (mean ± S.E.). The aromatase-rich regions (thalamus, amygdala, and hypothalamus) and the reference region for Logan reference tissue model analysis (cerebellum) are shown. The [11C]iso-cetrozole curves demonstrate rapid clearance from the tissues in comparison with cetrozole.
Figure 7
Figure 7
BPND values in the thalamus, hypothalamus, amygdala, white matter, temporal cortex, and nucleus accumbens of [11C]cetrozole (N = 21) and [11C]iso-cetrozole (N = 6) in the human brain. Each dot indicates individual value. Mean and 95% confidence intervals are also shown. In the hypothalamus, [11C]iso-cetrozole showed significantly higher BPND than [11C]cetrozole. No significant difference was observed between the BPND of [11C]iso-cetrozole and [11C]cetrozole in the other regions.
Figure 8
Figure 8
Parent composition of [11C]cetrozole (A, N = 21) and [11C]iso-cetrozole (B, N = 5) in human plasma (mean ± SD). The parent fraction of [11C]cetrozole and [11C]iso-cetrozole remained 80% and 27%, respectively, at 20 min after the injection.

Similar articles

Cited by

References

    1. Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology. 2006;31:1097–1111. doi: 10.1038/sj.npp.1301067. - DOI - PMC - PubMed
    1. Merlo S, Spampinato SF, Sortino MA. Estrogen and Alzheimer's disease: Still an attractive topic despite disappointment from early clinical results. Eur. J. Pharmacol. 2017;817:51–58. doi: 10.1016/j.ejphar.2017.05.059. - DOI - PubMed
    1. Seidman SN. Testosterone deficiency and mood in aging men: Pathogenic and therapeutic interactions. World J. Biol. Psychiatry. 2003;4:14–20. doi: 10.3109/15622970309167905. - DOI - PubMed
    1. Seidman SN. Normative hypogonadism and depression: Does 'andropause' exist? Int. J. Impot. Res. 2006;18:415–422. doi: 10.1038/sj.ijir.3901443. - DOI - PubMed
    1. Moraga-Amaro, R., van Waarde, A., Doorduin, J. & de Vries, E. F. J. Sex steroid hormones and brain function: PET imaging as a tool for research. J. Neuroendocrinol.30, e12565. 10.1111/jne.12565 (2018). - PMC - PubMed

Publication types